Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Dec 13, 2022 1:24pm
131 Views
Post# 35168932

RE:RE:RE:RE:Tactics used x Hedge Fund & MM to acquire shareholder stock

RE:RE:RE:RE:Tactics used x Hedge Fund & MM to acquire shareholder stockKnowing that ONCY us running out of time to find a suitor is valuable... Might save some potential investors from losing it on this wannabe bride, already jilted by Pfizer after just one year.

a bad actor - hmm, is that someone who just happens to have a more realistic appraisal of the facts... 

Noteable, you have been spinning fantasies of billion dollar takeover's for years.

IF, ONCY is bought out, for 5 billion or whatever inflated value you claim is true, that would be 50 times current pps...

Are you mental..? NO, ONCY would need to be valued at 2.5 Billion, and then the company bought out for double the stiock price at the time of the offer...

So HOW does ONCY get to a valuation of 2.5 billion, if even the recent, 'brilliant' data has shifted us mere pennies... you are the paid SCHILL. I work for no-one. I want this pos sold too... but what you suggest is complete BS.
<< Previous
Bullboard Posts
Next >>